Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05027425
Title Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Davendra Sohal
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.